Anne-Charlotte Rivière > Goodwin > Paris, France > Lawyer Profile
Goodwin Offices

12, RUE D'ASTORG
75008 PARIS
France
- Firm Profile
- Go to...
Anne-Charlotte Rivière

Position
Partner
Career
Anne-Charlotte Rivière is a partner in Goodwin’s Life Sciences and Technology groups. Anne-Charlotte focuses on transactions in the life sciences and technology sectors, acting for companies at all stages of development, as well as investors and management teams.
She guides these companies beyond their equity financing on all their strategic challenges including collaboration, mergers and acquisitions, public offerings and reorganization.
Anne-Charlotte also assists private equity funds in their leveraged buy-out (LBO) transactions in several sectors including the healthcare and other regulated sectors.
She is also regularly involved in secondary transactions.
Education
LLM, University d’Exeter (International Business Law) / DESS, University of Paris-Dauphine (Business Law) / Master, University of Paris-Dauphine (Management)
Lawyer Rankings
France > Industry focus: Healthcare and life sciences
(Next Generation Partners)Goodwin houses a broad offering known for its strength in financing mandates, patent infringement actions, and co-development and distribution agreements. Anne-Charlotte Rivière heads the practice, and is recognised for her vast expertise in venture capital, private equity, and M&A work within the life sciences space, particularly in relation to fundraisings. Rivière assists both global and domestic life sciences venture funds. Marie Fillon leads the firm’s IP group, with her primary area of expertise being collaboration, R&D, and manufacturing agreements.
France > Private equity: venture/growth capital
(Next Generation Partners)The practice group at Goodwin routinely assists venture and growth capital funds with the gamut of fundraising, governance and growth matters. Startups in the manufacturing, healthtech and biotech segments regularly feature on the team’s client roster. Leadership is shared between Anne-Charlotte Rivière, who focuses on venture capital in the life sciences and technology sectors; the ‘very experienced’ Thomas Dupont-Sentilles; and Xavier Leroux, who assists startups and scale-ups throughout the corporate life cycle. A recent standout matter saw the group advise H Company on its incorporation, followed by its $220m SeriesSeed financing from VC funds. Félicien Bardsley left the firm in January 2024.
Paris > Secteurs et industries > Santé et sciences de la vie
(Les grands avocats de demain)Goodwin est reconnu pour ses expertises en financement, en contentieux de brevets et en matière de négociation d’accords de codéveloppement et de distribution. La pratique est dirigée par Anne-Charlotte Rivière, une spécialiste du capital-risque, du capital-investissement et des fusions-acquisitions dans le domaine des sciences de la vie qui assiste des fonds de capital-risque français et internationaux (notamment lors de levées de fonds). A la tête de la pratique de PI, Marie Fillon assiste ses clients dans la négociation d’accords industriels, de collaboration et de R&D.
Paris > Private equity > Capital risque et capital développement
(Les grands avocats de demain)Goodwin assiste des fonds de capital-risque et de capital-développement sur la gestion de l’ensemble de leurs opérations transactionnelles et dossiers de gouvernance, ainsi que des startups spécialisées dans les secteurs de l’industrie et des biotech. La pratique est codirigée par Anne-Charlotte Rivière, qui intervient dans des deals de capital-risque dans les secteurs des sciences de la vie et des technologies ; le «très expérimenté » Thomas Dupont-Sentilles; et Xavier Leroux, qui conseille des startups sur l’ensemble de leurs besoins. Le cabinet a conseillé H Company sur la création de sa startup et sur une levée de fonds de 220 millions de dollars. Félicien Bardsley a quitté le cabinet en janvier 2024.
Lawyer Rankings
- Next Generation Partners France > Industry focus: Healthcare and life sciences
- Next Generation Partners France > Private equity: venture/growth capital
- Private equity: venture/growth capital France
- Industry focus: Healthcare and life sciences France